FIELD: medicine.
SUBSTANCE: invention relates to a method of treating or reducing insulin resistance in susceptible warm-blooded animals, including people. Method includes introduction of a selective estrogen receptor modulator (SERM).
EFFECT: described is SERM combination with an amount of estrogen or a precursor of a sexual steroid hormone, selected from a group, consisting of dehydroepiandrosterone, dehydroepiandrosterone sulfate, androst-5-en-3b,17b-diol and compounds, converted in vivo into one of the said precursors or estrogen.
2 cl, 13 ex, 13 tbl, 8 dwg
